JournalsHub
.online
Find My Journal
ST

Suzanne L. Topalian

Bloomberg (United States) US

ORCID 0000-0002-0821-8587
360
Publications
96,748
Citations
101
H-Index
212
i10-Index
10.5
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer OA
Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer, Scott Gettinger, David C. Smith +25 more
New England Journal of Medicine 2012
12,546
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer OA
Julie R. Brahmer, Scott S. Tykodi, Laura Q.M. Chow, Wen-Jen Hwu, Suzanne L. Topalian +21 more
New England Journal of Medicine 2012
7,950
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy OA
Suzanne L. Topalian, Charles G. Drake, Drew M. Pardoll
Cancer Cell 2015
4,171
Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates OA
Julie R. Brahmer, Charles G. Drake, Ira Wollner, John D. Powderly, Joel Picus +15 more
Journal of Clinical Oncology 2010
2,914
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes OA
Mark E. Dudley, John R. Wunderlich, Paul F. Robbins, James Chih‐Hsin Yang, Patrick Hwu +14 more
Science 2002
2,801

Publications

357 total

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer PDF

Patrick M. Forde, Jamie E. Chaft, Kellie N. Smith, Valsamo Anagnostou, Tricia R. Cottrell et al. - New England Journal of Medicine, 2018
Cited by 2,104 OpenAlex

Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy PDF

Suzanne L. Topalian, Janis M. Taube, Robert A. Anders, Drew M. Pardoll - Nature reviews. Cancer, 2016
Cited by 2,685 OpenAlex

Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy PDF

Suzanne L. Topalian, Charles G. Drake, Drew M. Pardoll - Cancer Cell, 2015
Cited by 4,171 OpenAlex

Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy PDF

Janis M. Taube, Alison Klein, Julie R. Brahmer, Haiying Xu, Xiaoyu Pan et al. - Clinical Cancer Research, 2014
Cited by 2,321 OpenAlex

Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab

Suzanne L. Topalian, Mario Sznol, David F. McDermott, Harriet M. Kluger, Richard D. Carvajal et al. - Journal of Clinical Oncology, 2014
Cited by 2,199 OpenAlex

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer PDF

Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer, Scott Gettinger, David C. Smith et al. - New England Journal of Medicine, 2012
Cited by 12,546 OpenAlex

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer PDF

Julie R. Brahmer, Scott S. Tykodi, Laura Q.M. Chow, Wen-Jen Hwu, Suzanne L. Topalian et al. - New England Journal of Medicine, 2012
Cited by 7,950 OpenAlex

Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape

Janis M. Taube, Robert A. Anders, Geoffrey D. Young, Haiying Xu, Rajni Sharma et al. - Science Translational Medicine, 2012
Cited by 2,126 OpenAlex

Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates PDF

Julie R. Brahmer, Charles G. Drake, Ira Wollner, John D. Powderly, Joel Picus et al. - Journal of Clinical Oncology, 2010
Cited by 2,914 OpenAlex

Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes PDF

Richard A. Morgan, Mark E. Dudley, John R. Wunderlich, Marybeth S. Hughes, James Chih‐Hsin Yang et al. - Science, 2006
Cited by 2,561 OpenAlex

Research Topics

Cancer Immunotherapy and Biomarkers (205) Immunotherapy and Immune Responses (152) CAR-T cell therapy research (86) Immune Cell Function and Interaction (64) T-cell and B-cell Immunology (38)

Frequent Co-Authors

DR
Drew M. Pardoll
9 joint publications
JA
Janis M. Taube
7 joint publications
JU
Julie R. Brahmer
6 joint publications
JA
James Chih‐Hsin Yang
6 joint publications
ST
Steven A. Rosenberg
6 joint publications
RO
Robert A. Anders
5 joint publications

Affiliations

National Institutes of Health
US 2007 - 1987
Bloomberg (United States)
US 2025 - 2016
American Society of Clinical Oncology
US 2006 - 2006
The University of Texas MD Anderson Cancer Center
US 2010 - 2010
Howard Hughes Medical Institute
US 2003 - 2003

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now